APELLIS PHARMACEUTICALS, INC. SHAREHOLDERS HAVE AN OPPORTUNITY TO RECOVER THEIR INVESTMENT LOSSES
Apellis Pharmaceuticals, Inc.
Certification and Authorization of Plaintiff Pursuant to Federal Securities Laws
The individual or entity listed below (the "Plaintiff") authorizes and, upon execution of the accompanying retainer agreement by Bernstein Liebhard LLP, retains Bernstein Liebhard LLP to file an action under the federal securities laws to recover damages and to seek other relief against Apellis Pharmaceuticals, Inc.. Bernstein Liebhard LLP will prosecute the action on a contingent fee basis and will advance all costs and expenses. The Apellis Pharmaceuticals, Inc. Retention Agreement provided to the Plaintiff is incorporated by reference, upon execution by Bernstein Liebhard LLP.